Brainshark Named Best Training Solution in 2019 Golden Bridge Awards®

WALTHAM, Mass., Sept. 26, 2019 /PRNewswire/ — Brainshark, Inc., delivering SaaS-based sales enablement and readiness solutions, today announced it is a winner in the 2019 Golden Bridge Awards®. Brainshark’s suite of sales readiness solutions was named a gold (highest-level) winner in the “Best Product: Training” category – recognized for fostering better-prepared, results-driven sales forces.

The Golden Bridge Awards celebrate the world’s best in organizational performance, products and services, executives, management teams and more. Organizations worldwide – public and private, for-profit and non-profit, large and small – are eligible to submit nominations. This marks Brainshark’s sixth year as a winner in the program.

Brainshark’s sales readiness platform – also honored last month in The 2019 International Business Awards® – prepares sales teams with the knowledge and resources they need, right when they need them, so they’re ready for each unique selling situation. Judges recognized Brainshark’s multi-pronged approach to sales enablement, with solutions for:

Brendan Cournoyer, vice president of marketing at Brainshark, said: “Today’s client-facing teams need a lot of knowledge to be effective, and that information is always changing. It’s why sales readiness has become such a critical discipline. Year after year, research shows that readiness and training services – such as onboarding, skills development and coaching – are the most critical responsibilities of sales enablement. We’re extremely proud to be recognized again in the Golden Bridge Awards for the impact our platform makes every day to elevate those strategies and for our commitment to driving perpetual sales readiness for our customers.”

For more information on Brainshark’s sales readiness solutions and the positive and dramatic business results customers achieve, please visit www.brainshark.com/success.

About Brainshark
Brainshark’s sales readiness platform gives you the tools to prepare all your client-facing teams with the knowledge and skills they need to perform at the highest level. With best-of-breed solutions for training, coaching, content and more, you can ensure reps are always ready to make the most of any selling situation. With Brainshark, companies can: enable sales teams with on-demand training that accelerates onboarding and keeps reps up-to-speed; validate readiness with sales coaching and practice that ensures reps master your message; and empower sales organizations with rich, dynamic content that can be created quickly, updated easily and accessed anywhere. Thousands of companies – including more than half of the Fortune 100 – rely on Brainshark to get better results from their sales enablement initiatives. Learn more at www.brainshark.com.

Media Contact:
Lauren Boutwell
Email: press@brainshark.com
Phone: 781.370.8295

View original content to download multimedia:http://www.prnewswire.com/news-releases/brainshark-named-best-training-solution-in-2019-golden-bridge-awards-300925735.html

SOURCE Brainshark, Inc.

Staff

Recent Posts

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

27 minutes ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

27 minutes ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

15 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

15 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

15 hours ago